Adiponectin depletion leads to reduced efficiency in energy expenditure, reduced glucose utilization, thereby increasing the risk of type 2 diabetes mellitus (T2DM), CVD, colorectal cancer and nonalcoholic fatty liver disease [49,50,51,52]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.